These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26999939)

  • 41. [Combined intravitreal injection of bevacizumab and SF6 gas for treatment of submacular hemorrhage secondary to age-related macular degeneration].
    Höhn F; Mirshahi A; Hattenbach LO
    Ophthalmologe; 2010 Apr; 107(4):328-32. PubMed ID: 19669150
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Results of intravitreal tissue plasminogen activator and expansile gas injection for submacular haemorrhage in Thais.
    Ratanasukon M; Kittantong A
    Eye (Lond); 2005 Dec; 19(12):1328-32. PubMed ID: 15565185
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Management of subretinal hemorrhage with r-TPA, SF-6 and ranibizumab].
    Gros-Otero J; Benítez-Herreros J; Beckford-Torngren C; Cámara-González C; Castro-Rebollo M
    Arch Soc Esp Oftalmol; 2010 Mar; 85(3):114-7. PubMed ID: 20619123
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pneumatic displacement of submacular hemorrhage.
    Hesse L; Kroll P
    Ophthalmology; 2000 Dec; 107(12):2119-20. PubMed ID: 11097565
    [No Abstract]   [Full Text] [Related]  

  • 45. Management of submacular hemorrhage with intravitreal injection of tissue plasminogen activator and expansile gas.
    Chen CY; Hooper C; Chiu D; Chamberlain M; Karia N; Heriot WJ
    Retina; 2007 Mar; 27(3):321-8. PubMed ID: 17460587
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Traumatic submacular hemorrhage treated with rt-PA and SF6].
    Heras-Mulero H; García-Gómez PJ; Sádaba-Echarri LM; Salinas-Alamán A; García-Layana A
    Arch Soc Esp Oftalmol; 2007 Aug; 82(8):517-20. PubMed ID: 17717774
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravitreal tissue plasminogen activator in submacular haemorrhage.
    Singh P; Singh R; Kishore KS; Vig VK; Singh R; Singh B
    Indian J Ophthalmol; 1999 Dec; 47(4):254-5. PubMed ID: 10892486
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Subretinal tissue plasminogen activator injection to treat submacular haemorrhage during age-related macular degeneration.
    Dewilde E; Delaere L; Vaninbroukx I; Van Calster J; Stalmans P
    Acta Ophthalmol; 2014 Sep; 92(6):e497-8. PubMed ID: 24943231
    [No Abstract]   [Full Text] [Related]  

  • 49. Vitreous hemorrhage complicating intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage.
    Wu TT; Kung YH; Hong MC
    Retina; 2011 Nov; 31(10):2071-7. PubMed ID: 21817964
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Literature review of recombinant tissue plasminogen activator used for recent-onset submacular hemorrhage displacement in age-related macular degeneration.
    van Zeeburg EJ; van Meurs JC
    Ophthalmologica; 2013; 229(1):1-14. PubMed ID: 23075629
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of intravitreal gas with or without tissue plasminogen activator on submacular haemorrhage in age-related macular degeneration.
    Fang IM; Lin YC; Yang CH; Yang CM; Chen MS
    Eye (Lond); 2009 Feb; 23(2):397-406. PubMed ID: 17975562
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Management of submacular hemorrhage by tissue plasminogen activator and SF(6) gas injection].
    Meier P; Zeumer C; Jochmann C; Wiedemann P
    Ophthalmologe; 1999 Oct; 96(10):643-7. PubMed ID: 10552156
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pneumatic displacement of submacular hemorrhage due to age-related macular degeneration.
    Ron Y; Ehrlich R; Axer-Siegel R; Rosenblatt I; Weinberger D
    Ophthalmologica; 2007; 221(1):57-61. PubMed ID: 17183203
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in Age-Related macular degeneration.
    Olivier S; Chow DR; Packo KH; MacCumber MW; Awh CC
    Ophthalmology; 2004 Jun; 111(6):1201-8. PubMed ID: 15177972
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intravitreal ranibizumab for choroidal neovascularization with large submacular hemorrhage in age-related macular degeneration.
    Iacono P; Parodi MB; Introini U; La Spina C; Varano M; Bandello F
    Retina; 2014 Feb; 34(2):281-7. PubMed ID: 23851632
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Treatment of hematomas in age related macular degeneration by vitrectomy and subretinal injection of r-tPA: Preliminary results (French translation of the article)].
    Boiché M; Angioi-Duprez K; Conart JB; Berrod JP
    J Fr Ophtalmol; 2020 Jan; 43(1):43-50. PubMed ID: 31870667
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intravitreal bevacizumab therapy for neovascular age-related macular degeneration with large submacular hemorrhage.
    Stifter E; Michels S; Prager F; Georgopoulos M; Polak K; Hirn C; Schmidt-Erfurth U
    Am J Ophthalmol; 2007 Dec; 144(6):886-892. PubMed ID: 17916314
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vitreous hemorrhage after intravitreal tissue plasminogen activator (t-PA) and pneumatic displacement of submacular hemorrhage.
    Kokame GT
    Am J Ophthalmol; 2000 Apr; 129(4):546-7. PubMed ID: 10764874
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of submacular haemorrhage in patients with neovascular age related macular degeneration.
    Lumi X; Sulak M
    Coll Antropol; 2013 Apr; 37 Suppl 1():223-6. PubMed ID: 23837248
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-vascular endothelial growth factor with or without pneumatic displacement for submacular hemorrhage.
    Shin JY; Lee JM; Byeon SH
    Am J Ophthalmol; 2015 May; 159(5):904-14.e1. PubMed ID: 25637179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.